US Patent Litigations are now available. Check here

Explore Ariad Pharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent NumberGrant DateTitleTotal Oppositions
EP2300013Nov 13, 2024Phosphorous Derivatives As Kinase Inhibitors2